Based on our results, we can suggest greater utility of serum TIMP-1 compared with MMP-9, MMP-2, and TIMP-2 in the diagnosis of CRC, particularly in the assessment of the tumor stage, survival of cancer patients, resectability of the tumor, and in the differentiation between CA and CRC. The gene discussed is TIMP2; the disease is cancer.